SecSonar.com

BrainsWay Ltd. (BWAY)

BrainsWay Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

BrainsWay Ltd. (BWAY) is a Medical - Devices company based in IL with a market capitalization of $613.4M. Revenue grew 27.3% year-over-year and the company generated $16.4M in free cash flow. This page tracks BWAY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 120 employees · IPO Apr 17, 2019

Valuation

Valuation & price

$15.95 · as of May 26, 2026 · -7.1% vs 52w high

44.3

P/E ratio

Latest-FY diluted EPS

8.38

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$17.17$11.49$5.81Jul 25Dec 25Jul 26Jul 7, 25$6.69Jul 9, 25$6.50Jul 11, 25$6.16Jul 15, 25$6.10Jul 17, 25$5.81Jul 21, 25$6.05Jul 23, 25$5.95Jul 25, 25$5.87Jul 29, 25$5.92Jul 31, 25$5.84Aug 4, 25$5.86Aug 6, 25$5.92Aug 11, 25$6.05Aug 13, 25$6.35Aug 15, 25$6.49Aug 19, 25$7.24Aug 21, 25$7.50Aug 25, 25$7.68Aug 27, 25$7.63Aug 29, 25$7.78Sep 3, 25$7.84Sep 5, 25$7.93Sep 9, 25$7.96Sep 11, 25$7.85Sep 16, 25$8.45Sep 18, 25$7.98Sep 22, 25$7.76Sep 24, 25$7.46Sep 26, 25$7.33Sep 30, 25$7.54Oct 2, 25$7.46Oct 6, 25$7.62Oct 8, 25$7.77Oct 10, 25$7.54Oct 14, 25$7.58Oct 16, 25$8.00Oct 21, 25$8.14Oct 23, 25$8.32Oct 27, 25$8.51Oct 29, 25$8.40Oct 31, 25$8.43Nov 4, 25$8.36Nov 6, 25$7.80Nov 10, 25$8.06Nov 12, 25$7.89Nov 14, 25$7.88Nov 18, 25$7.39Nov 20, 25$7.25Nov 25, 25$7.70Nov 28, 25$8.74Dec 2, 25$8.65Dec 4, 25$8.57Dec 8, 25$8.86Dec 10, 25$8.95Dec 12, 25$8.49Dec 16, 25$8.44Dec 18, 25$8.10Dec 22, 25$9.41Dec 24, 25$9.65Dec 29, 25$9.52Jan 2, 26$9.65Jan 6, 26$10.68Jan 8, 26$11.55Jan 12, 26$12.10Jan 14, 26$11.78Jan 16, 26$11.59Jan 21, 26$11.59Jan 23, 26$11.52Jan 27, 26$12.81Jan 29, 26$12.03Feb 2, 26$11.63Feb 4, 26$11.08Feb 9, 26$11.28Feb 11, 26$11.72Feb 13, 26$11.50Feb 18, 26$13.02Feb 20, 26$12.06Feb 24, 26$12.21Feb 26, 26$11.71Mar 2, 26$11.85Mar 4, 26$12.45Mar 6, 26$12.34Mar 10, 26$12.71Mar 12, 26$13.74Mar 17, 26$13.73Mar 19, 26$13.93Mar 23, 26$13.71Mar 25, 26$13.86Mar 27, 26$12.87Mar 31, 26$13.29Apr 2, 26$13.57Apr 7, 26$12.26Apr 9, 26$14.30Apr 13, 26$14.39Apr 15, 26$15.81Apr 17, 26$15.81Apr 22, 26$15.85Apr 24, 26$16.37Apr 28, 26$16.10Apr 30, 26$16.56May 4, 26$16.42May 6, 26$16.41May 8, 26$17.17May 12, 26$16.74May 14, 26$16.32May 18, 26$14.88May 20, 26$15.28May 22, 26$15.10May 28, 26$15.88Jun 1, 26$15.44Jun 3, 26$14.04Jun 5, 26$13.89Jun 9, 26$14.43Jun 11, 26$14.69Jun 15, 26$14.33Jun 17, 26$14.41Jun 22, 26$14.38Jun 24, 26$14.40Jun 26, 26$14.48Jul 2, 26$15.19
$5.7452-week range$17.17
Loading valuation history…

Fundamentals

Key fundamentals

$613.4M

Market cap

27.3%

Revenue growth (YoY)

75.4%

Gross margin

$16.4M

Free cash flow (USD)

-$62.3M

Net debt

Net cash position

-43.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$11.5MFY 2017$11.1MFY 2018$16.4MFY 2019$23.1MFY 2020$22.1MFY 2021$29.7MFY 2022$27.2MFY 2023$31.8MFY 2024$41.0MFY 2025$52.2M
$11.5M$52.2M

Free cash flow by year

2016 → 2025

FY 2016$-2.8MFY 2017$-4.5MFY 2018$-5.7MFY 2019$-10.6MFY 2020$-3.9MFY 2021$-1.4MFY 2022$-9.8MFY 2023$-1.1MFY 2024$6.5MFY 2025$16.4M
-$2.8M$16.4M

Gross margin by year

2021 → 2025

FY 202177.8%FY 202273.8%FY 202373.9%FY 202474.6%FY 202575.4%
77.8%75.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

3

Insider sells · 90 days

Earnings

Last report: 6-K filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingPositive Study ResultsJun 29, 2026Filing
  • 6-K filingRegulatory UpdateJun 22, 2026Filing
  • Insider sellInsider SellMoiseyev Gilad · Chief Technology OfficerJun 22, 2026Filing
  • 6-K filingClinical Data PresentationJun 9, 2026Filing
  • Insider sellInsider SellRoth Yiftach · Chief ScientistJun 3, 2026Filing
  • Insider sellInsider SellMitrany Rayten Michal Ety · DirectorMay 26, 2026Filing
  • 6-K filingMinority-Stake InvestmentMay 18, 2026Filing
  • Annual reportAnnual Report FiledMay 13, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 13, 2026Filing
  • Annual report20-F FiledApr 20, 2026Filing

Questions

Frequently asked questions

What is BrainsWay Ltd.'s market cap?

BrainsWay Ltd. (BWAY) has a market capitalization of $613.4M.

What is BWAY's P/E ratio?

BWAY trades at a price-to-earnings ratio of 44.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is BWAY's price-to-book (P/B) ratio?

BWAY trades at 8.38 times book value per share.

Are insiders buying BWAY stock?

SEC Form 4 filings show no open-market insider buys at BrainsWay Ltd. in the last 90 days (3 sells).

Same arena

Related companies in Medical - Devices

CERS

Cerus Corporation

$612.8M

SIBN

SI-BONE, Inc.

$631.8M

NPCE

NeuroPace, Inc.

$590.8M

BVS

Bioventus Inc.

$580.6M

TCMD

Tactile Systems Technology, Inc.

$560.5M

CTKB

Cytek Biosciences, Inc.

$551.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.